[Citrullination and rheumatoid arthritis]

Area of Science:

• Immunology
• Rheumatology
• Molecular Biology

Background:

• Anti-citrullinated peptide antibody (ACPA) is a key biomarker for rheumatoid arthritis (RA) diagnosis and prognosis.
• ACPA and citrullinated epitope-specific T cells contribute to RA pathogenesis, including osteoclastogenesis.
• Neutrophil extracellular traps (NETs), rich in citrullinated histones, are implicated as a source of citrullinated antigens in RA.

Purpose of the Study:

• To investigate the role of peptidylarginine deiminase (PADI) 4 in RA pathogenesis.
• To explore the significance of PADI4 in NETosis and its contribution to arthritis.
• To evaluate the potential of targeting citrullinated epitopes for RA therapy.

Main Methods:

• Analysis of PADI4-deficient mice to study its role in arthritis.
• Investigation of citrullinated antigens within neutrophil extracellular traps (NETs).
• Exploration of T cell responses to citrullinated epitopes.

Main Results:

• PADI4 plays a pivotal role in NETosis, a process relevant to RA pathogenesis.
• PADI4 deficiency impacts arthritis development, highlighting its importance.
• NETs contain abundant citrullinated histones, serving as a source of citrullinated antigens.

Conclusions:

• PADI4 is a significant factor in RA pathogenesis, particularly through its role in NET formation.
• Targeting citrullinated epitopes, potentially involving PADI4 and NETs, represents a promising therapeutic strategy for RA.
• Further research into PADI4 and citrullinated antigens could lead to novel RA treatments.